Showing results (1081-1090 of 1,133) with videos related to
Sort By:
Pageof 114
Eclinicalmedicine|February 19, 2024
Improving survival in advanced melanoma patients: a trend analysis from 2013 to 2021Olivier J van Not, Alfons J M van den Eertwegh, John B Haanen, et al.British Journal of Cancer|April 15, 2025
Adjuvant BRAF/MEK versus anti-PD-1 in BRAF-mutant melanoma: a propensity score matched survival analysisM Bloem, M M de Meza, A J M van den Eertwegh, et al.Pigment Cell & Melanoma Research|August 9, 2023
Seasonal variation of anti-PD-1 outcome in melanoma-Results from a Dutch patient cohortJ S W Borgers, F H Burgers, A Schina, et al.European Journal of Nuclear Medicine and Molecular Imaging|February 23, 2021
An international expert opinion statement on the utility of PET/MR for imaging of skeletal metastasesJad S Husseini, Bárbara Juarez Amorim, Angel Torrado-Carvajal, et al.Cancers|April 25, 2020
Healthcare Costs of Metastatic Cutaneous Melanoma in the Era of Immunotherapeutic and Targeted DrugsBrenda Leeneman, Carin A Uyl-de Groot, Maureen J B Aarts, et al.International Journal of Cancer|June 20, 2020
Real-world outcomes of advanced melanoma patients not represented in phase III trialsMichiel C T van Zeijl, Rawa K Ismail, Liesbeth C de Wreede, et al.British Journal of Cancer|April 28, 2025
Rechallenge of ipilimumab and nivolumab in advanced melanoma patients after previous ipilimumab-based therapyE J van Dijk, H H Nienhuis, A J M van den Eertwegh, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 23, 2013
The Dutch surgical colorectal auditN J Van Leersum, H S Snijders, D Henneman, et al.ESMO Open|November 17, 2020
Lower risk of severe checkpoint inhibitor toxicity in more advanced diseaseRik J Verheijden, Anne M May, Christian U Blank, et al.Annals of Surgery|June 3, 2025
Routine Imaging After Resection of Pancreatic Ductal Adenocarcinoma: Nationwide Utilization and Survival AnalysisIris W J M van Goor, Paul C M Andel, Simone Augustinus, et al.Pageof 114